HealthEquity, Inc. $HQY Shares Sold by Summit Creek Advisors LLC

Summit Creek Advisors LLC lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 16.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 70,693 shares of the company’s stock after selling 13,464 shares during the quarter. HealthEquity comprises 2.5% of Summit Creek Advisors LLC’s portfolio, making the stock its 11th biggest holding. Summit Creek Advisors LLC’s holdings in HealthEquity were worth $6,254,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in HealthEquity in the 2nd quarter worth approximately $1,018,621,000. Wasatch Advisors LP raised its holdings in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after acquiring an additional 757,801 shares in the last quarter. William Blair Investment Management LLC purchased a new stake in shares of HealthEquity during the 2nd quarter worth approximately $160,158,000. Dimensional Fund Advisors LP boosted its position in shares of HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock valued at $135,957,000 after acquiring an additional 45,287 shares during the last quarter. Finally, Bank of America Corp DE bought a new position in shares of HealthEquity during the 2nd quarter valued at approximately $103,573,000. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HQY. BMO Capital Markets raised their target price on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Weiss Ratings raised shares of HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 2nd. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research report on Monday, August 31st. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $113.53.

Insider Activity

In other news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the transaction, the director owned 62,395 shares in the company, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by insiders.

HealthEquity Trading Up 0.2%

HQY opened at $103.63 on Friday. The firm has a market cap of $8.57 billion, a P/E ratio of 37.41, a P/E/G ratio of 1.64 and a beta of 0.22. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $110.26. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. The stock has a 50-day moving average of $95.52 and a 200 day moving average of $89.51.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. The firm’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts forecast that HealthEquity, Inc. will post 3.94 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits.

Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Founded in 2002, HealthEquity is based in Draper, Utah, and serves customers across the United States.